Predilife S.A.
PAR: ALPRE.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Stephane Ragusa
- Employees
- 19
- Headquarters
- Villejuif, France
- IPO year
- 2018
- Market cap
- €11.7M
- Website
- https://www.predilife.com
Loading ALPRE…
Loading profile data…Frequently asked questions about ALPRE
What does Predilife S.A. (ALPRE.PA) do?
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device...
Where does ALPRE.PA trade?
Predilife S.A. (ALPRE.PA) trades on the Euronext Paris.
What sector is ALPRE.PA in?
Predilife S.A. (ALPRE.PA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Predilife S.A.?
Stephane Ragusa is the chief executive officer of Predilife S.A. (ALPRE.PA).
Where is Predilife S.A. headquartered?
Predilife S.A. is headquartered in France.
Does ALPRE.PA pay a dividend?
Predilife S.A. (ALPRE.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALPRE.PA go public?
Predilife S.A. (ALPRE.PA) completed its initial public offering in 2018.